Prabha Raghavan
Authors you can follow
More From Prabha Raghavan
Bharat Biotech nixes Covaxin supply pact with Precisa in Brazil
It is unclear at this stage whether the Hyderabad-based vaccine maker’s decision to terminate its November 24 contract with Precisa Medicamentos and Envixia Pharmaceuticals is a result of the controversy.
Sat, Jul 24, 2021
Sputnik too in Serum stable, plans 300 million doses a year
Russia's Sputnik V vaccine, developed by Gamaleya National Research Institute of Epidemiology and Microbiology in Moscow, was granted emergency use authorisation in India in May.
Wed, Jul 14, 2021
PLI schemes evoke mixed response: IT, mobile steal a march on other sectors
The government had to, for instance, re-open applications for its PLI scheme for medical devices due to certain issues faced in filling up the 28 slots the first time around.
Mon, Jul 12, 2021
Sanofi, GSK get nod for first global clinical trial with Indian population
Subject to “subsequent approvals”, enrollment of participants in the country “should soon begin”, said Annapurna Das, Country Head, Sanofi Pasteur India.
Fri, Jul 09, 2021
Zydus Cadila seeks nod for world’s first DNA Covid vaccine
If approved by the regulator, ZyCov-D will be the world's first DNA vaccine against infection with SARS-CoV-2.
Fri, Jul 02, 2021
Explained: How Zydus Cadila’s ZyCov-D vaccine for Covid-19 works, and how it is different
Zydus Cadila ZyCov-D vaccine: ZyCov-D is a “plasmid DNA” vaccine — or a vaccine that uses a genetically engineered, non-replicating version of a type of DNA molecule known as a 'plasmid'.
Fri, Aug 20, 2021
Government gives Moderna emergency use nod, may first come in only as donations
While the government said details on the quantity of doses to be imported to India by Cipla are still under consideration, The Indian Express has learnt that the vaccine is initially expected to be provided to India in limited quantities — as donations by the US drug maker.
Wed, Jun 30, 2021
Explained: How to link your passport with Covid-19 vaccine certificate
If you are traveling out of India to study, for a job or for the Tokyo Olympic games, it is likely that you may be asked for a Covid-19 vaccine certificate linked to your passport.
Wed, Jul 21, 2021
Covaxin Phase 3 data in: Efficacy 77.8% against symptomatic Covid
The results of the phase 3 trials come a day before the Hyderabad company’s scheduled meeting with the World Health Organization (WHO), where it is expected to submit its proposal for an Emergency Use Listing of the vaccine.
Wed, Jun 23, 2021
Explained: Monoclonal antibodies and Covid-19
Trials in the UK have found a monoclonal antibody cocktail effective in some patients with severe Covid-19. What is this treatment, how does it compare with plasma therapy, and how much promise does it hold?
Sun, Jun 27, 2021
Drones for vaccines: ICMR seeks bids, Telangana explores ‘Medicines from Sky’
Companies with logistics experience including Flipkart and Dunzo have announced their consortia under Telangana’s drone delivery scheme to develop and execute drone deliveries there.
Tue, Jun 15, 2021
SII-partner Novavax reports 90% efficacy, says focused first on developing countries
The Maryland-headquartered company said its vaccine had demonstrated 100 per cent protection in late-stage trials against moderate and severe disease caused by SARS-CoV-2 — a boost for the prospects of its Indian version, Covovax.
Tue, Jun 15, 2021
Vaccines for children: Plan to cover 80% over 12; Covaxin pegged to lead supply
Going by the 80 per cent coverage strategy, the government would have to plan for enough vaccines to cover 104 million children to effectively protect this cohort.
Mon, Jun 14, 2021
No emergency use, US FDA asks Bharat Biotech to obtain full approval
Ocugen, Bharat Biotech’s Covaxin partner in the US, “will no longer pursue an Emergency Use Authorization” of the vaccine in that country, the American clinical stage biopharmaceutical company told Nasdaq on Thursday.
Sat, Jun 12, 2021
Post reports of CoWin leak, IT Min asks CERT-In to probe
Sources at the IT Ministry said though the issue had been handled for now, CERT-In, with help of other domestic and global cybersecurity experts, was checking the entire CoWin platform once again to ensure there were no vulnerabilities.
Sat, Jun 12, 2021
Explained: What denial of US approval means for Covaxin, and students going there
The United States has decided not to give emergency use authorisation (EUA) to Bharat Biotech's Covid-19 vaccine, Covaxin. Does this mean there is something wrong with the vaccine?
Thu, Jun 17, 2021
Centre may renegotiate vaccine prices with SII and Bharat Biotech
When the Centre began vaccination in January, it procured 11 million doses of Covishield at Rs 200 each excluding taxes, and about 5.5 million doses of Covaxin at Rs 206 each excluding taxes. However, the prices were later negotiated downwards to Rs 150 per dose.
Thu, Jun 10, 2021
Explained: The merits and concerns of mixing Covid-19 vaccines
India is considering whether people can be given a mix of different Covid-19 vaccine doses. What can be the merits of such a programme, and what are the concerns? Which other countries are trying this?
Sat, Jun 04, 2022
Upfront payment a roadblock for vaccine availability, small hospitals lag behind
With smaller hospitals in non-metros facing difficulties procuring vaccines, AHPI has facilitated efforts to negotiate with vaccine makers on behalf of some of its members.
Tue, Jun 08, 2021
Explained: How is Biological E’s Corbevax different?
India has placed an advance order for 300 million doses of Corbevax. How does this Covid-19 vaccine work, and how does it differ from others? What could the order mean for India’s vaccination programme?
Thu, Jun 10, 2021
Substantial number of vaccine doses for India: US coordinator
The US will allocate doses to India based on factors such as the country’s vaccination plans, State Department Coordinator for Global Covid-19 Response Gayle E Smith said.
Sat, Jun 05, 2021
SII receives ‘preliminary’ permission to make test batches of Sputnik V vaccine
The company on Friday received Drug Controller General of India Dr V G Somani's permission to manufacture batches of Sputnik V “for test and analysis”, a source close to the development told The Indian Express on condition of anonymity.
Sat, Jun 05, 2021
‘At-risk’ policy change: Govt puts money on new-platform Covid-19 vaccine
It is significant that the government has put its money on a novel platform for a Covid-19 vaccine that is yet to receive regulatory approval.
Tue, Jun 08, 2021
Pfizer, Cipla demands pending, DCGI relaxes norms for clearing vaccines
The move, which would make it easier for companies to bring their vaccines to India, follows similar demands raised by, among others, Pfizer and Cipla during negotiations to supply imported vaccines to the country.
Wed, Jun 02, 2021
Tests on mixed vaccines may start in a few weeks
The testing may be carried out both using vaccines that are currently available in the country, and those that are in the pipeline.
Mon, May 31, 2021